Orchestra BioMed Holdings Operating Margin Growth & History (OBIO)

Orchestra BioMed Holdings's operating margin was −154.73% for fiscal 2025.

View full Orchestra BioMed Holdings company overview

Orchestra BioMed Holdings annual operating margin history

Orchestra BioMed Holdings annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−154.73%+2282.76 pp
20242024-12-31−2,437.49%−571.33 pp
20232023-12-31−1,866.16%−941.82 pp
20222022-12-31−924.34%—

Orchestra BioMed Holdings operating margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Orchestra BioMed Holdings's operating margin increased from −924.34% to −154.73%, a change of +769.61 percentage points. The latest reported quarter, Q2 2026, shows −25,404.55%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Orchestra BioMed Holdings source filings ↗

Community posts

It’s quiet here.

No posts about OBIO yet. Start the conversation.

Write the first post